Registration of securities issued in business combination transactions

Share-Based Compensation (Tables) (Mymd Pharmaceuticals Inc.)

v3.20.4
Share-Based Compensation (Tables) (Mymd Pharmaceuticals Inc.)
 12 Months Ended
Dec. 31, 2020
Summary of Outstanding Stock Options Activity

The following table summarizes the option activities for the years ended December 31, 2020:

 

                      Weighted        
                      Average        
          Weighted     Weighted     Remaining        
    Number     Average     Average     Contractual     Aggregate  
    of     Exercise     Grant Date     Term     Intrinsic  
    Shares     Price     Fair Value     (years)     Value  
Balance at December 31, 2019     40     $ 236.16     $ 151.68       0.99     $ -  
Granted     -       -       -       -       -  
Exercised     -       -       -       -       -  
Forfeited     -       -       -               -  
Canceled/Expired     (40 )   $ 236.16     $ 151.68       0.24       -  
Balance at December 31, 2020     -     $ -     $ -       -     $ -  
Exercisable as of December 31, 2020     -     $ -     $ -       -     $ -  
Mymd Pharmaceuticals Inc. [Member]  
Summary of Outstanding Stock Options Activity

Following is the status of outstanding stock options as of December 31, 2020 and 2019 and changes therein for the years then ended:

 

          Weighted     Weighted
          Average     Average
    Number     Exercise     Remaining
    of Shares     Price     Life
Outstanding December 31, 2018     31,332,500     $ 1.00     9.21 Years
Granted     8,010,619     $ 1.00      
Outstanding December 31, 2019     39,343,119     $ 1.00     8.52 Years
Granted     2,810,241     $ 1.00      
Cancelled     (31,300,000 )   $ 1.00      
Outstanding December 31, 2020     10,853,360     $ 1.00     7.98 Years
Schedule of Fair Value Assumptions for Options

The following table shows the assumptions used in calculating the fair value under the Black-Scholes option valuation model for stock options issued by the Company during the years ended December 31, 2020 and 2019:

 

    December 31,     December 31,  
    2020     2019  
Common stock grant date fair value   $ 1.00     $ 1.00  
Risk free interest rate     0.27% - 1.43 %     1.37% - 2.42 %
Expected dividend yield     0 %     0 %
Expected term     5 years       5 years  
Expected stock volatility     73.0% - 75.8 %     70.9% - 72.4 %